ACP5 and hyperlipidemia: Specifically, serum TRACP-5a levels were correlated with elevated blood pressure, hyperlipidemia, and insulin resistance, and the TRACP-5a biomarker cut-off value of 5.8 μg/L was defined as indicative of higher MetS risk using c-statistics.